Cargando…

Modern Approaches to Lower Lipoprotein(a) Concentrations and Consequences for Cardiovascular Diseases

Lipoprotein(a) (Lp(a)) is a low density lipoprotein particle that is associated with poor cardiovascular prognosis due to pro-atherogenic, pro-thrombotic, pro-inflammatory and pro-oxidative properties. Traditional lipid-lowering therapy does not provide a sufficient Lp(a) reduction. For PCSK9 inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korneva, Victoria A., Kuznetsova, Tatjana Yurjevna, Julius, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469722/ https://www.ncbi.nlm.nih.gov/pubmed/34572458 http://dx.doi.org/10.3390/biomedicines9091271

Ejemplares similares

The Role of Cumulative LDL Cholesterol in Cardiovascular Disease Development in Patients with Familial Hypercholesterolemia
por: Korneva, Victoria, et al.
Publicado: (2022)

Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges
por: Packard, Chris, et al.
Publicado: (2021)

Lipoprotein(a) Lowering—From Lipoprotein Apheresis to Antisense Oligonucleotide Approach
por: Greco, Maria Francesca, et al.
Publicado: (2020)

Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection
por: Julius, Ulrich
Publicado: (2016)

Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
por: Robinson, Jennifer G., et al.
Publicado: (2018)

Low-density lipoprotein cholesterol lowering therapy for the secondary prevention of atherosclerotic cardiovascular disease
por: Patel, Parth N., et al.
Publicado: (2020)

Lipoprotein(a) in Cardiovascular Diseases
por: Malaguarnera, Michele, et al.
Publicado: (2013)

Low-density lipoprotein cholesterol lowering treatment: the current approach
por: Crismaru, Irina, et al.
Publicado: (2020)

Biomedical consequences of elevated cholesterol-containing lipoproteins and apolipoproteins on cardiovascular and non-cardiovascular outcomes
por: Schmidt, Amand F., et al.
Publicado: (2023)

Current Role of Lipoprotein Apheresis in the Treatment of High-Risk Patients
por: Julius, Ulrich
Publicado: (2018)

Clinical Challenges for Women of Modern Societies and Potential Cardiovascular Consequences
por: Becerra-Gonzales, Victor G., et al.
Publicado: (2020)

The consequences of modernity /
por: Giddens, Anthony
Publicado: (1990)

High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?
por: Márquez, Andrea Bonnin, et al.
Publicado: (2020)

Recent Updates of Lipoprotein(a) and Cardiovascular Disease
por: Liu, Taili, et al.
Publicado: (2021)

Peroxisome Proliferator-Activated Receptor α in Lipoprotein Metabolism and Atherosclerotic Cardiovascular Disease
por: Fuior, Elena Valeria, et al.
Publicado: (2023)

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
por: Shapiro, Michael D., et al.
Publicado: (2017)

Molecular and Cellular Mechanisms of Electronegative Lipoproteins in Cardiovascular Diseases
por: Ke, Liang-Yin, et al.
Publicado: (2020)

Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
por: Yanai, Hidekatsu, et al.
Publicado: (2022)

Aspirin in the Modern Era of Cardiovascular Disease Prevention
por: Murphy, Ella, et al.
Publicado: (2021)

High density lipoproteins-based therapies for cardiovascular disease
por: Gao, Xuan, et al.
Publicado: (2010)

Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease
por: Heo, Ji Hye, et al.
Publicado: (2023)

Why Some Patients Undergoing Lipoprotein Apheresis Therapy Develop New Cardiovascular Events?
por: Julius, Ulrich, et al.
Publicado: (2020)

Renal dysfunction in cardiovascular diseases and its consequences
por: Deferrari, Giacomo, et al.
Publicado: (2020)

Modern Approaches to Acellular Therapy in Bone and Dental Regeneration
por: Ivanov, Alexey A., et al.
Publicado: (2021)

Mass Spectrometry for the Monitoring of Lipoprotein Oxidations by Myeloperoxidase in Cardiovascular Diseases
por: Coremans, Catherine, et al.
Publicado: (2021)

Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
por: Toth, Peter P
Publicado: (2016)

Lipoprotein(a) and Cardiovascular Disease Prevention across Diverse Populations
por: Pearson, Keon, et al.
Publicado: (2020)

Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans
por: Doi, Takahito, et al.
Publicado: (2023)

Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
por: Szarek, Michael, et al.
Publicado: (2020)

PON1 concentration and high-density lipoprotein characteristics as cardiovascular biomarkers
por: González, Fátima E. Murillo, et al.
Publicado: (2019)

The Causes and Consequences of Low Levels of High Density Lipoproteins in Patients with Diabetes
por: Barter, Philip J.
Publicado: (2011)

Oxidized Low-Density Lipoprotein Serum Concentrations and Cardiovascular Morbidity in End Stage of Renal Disease †
por: Raikou, Vaia, et al.
Publicado: (2018)

Modern Approaches to Testing Drug Sensitivity of Patients’ Tumors (Review)
por: Druzhkova, I.N., et al.
Publicado: (2020)

Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries
por: Ezhov, Marat V., et al.
Publicado: (2021)

Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease
por: Estrada-Luna, Diego, et al.
Publicado: (2018)

A Review of Lipidomics of Cardiovascular Disease Highlights the Importance of Isolating Lipoproteins
por: Ding, Ming, et al.
Publicado: (2020)

Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?
por: Makris, Anastasios, et al.
Publicado: (2023)

Lipoprotein(a): Cardiovascular Disease, Aortic Stenosis and New Therapeutic Option
por: Maloberti, Alessandro, et al.
Publicado: (2022)

Evolutionary and Medical Consequences of Archaic Introgression into Modern Human Genomes
por: Dolgova, Olga, et al.
Publicado: (2018)

Cardiovascular Consequences of Cortisol Excess
por: Whitworth, Judith A, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_tfdoraj3elj9p9gapktes2hdju